LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.85 | 27.76 | 617 | 6062 | 0.1018 | 0.4905 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.85 | 27.76 | 8409 | 6062 | 1.3870 | 1.0860 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.85 | 27.76 | 7661 | 6062 | 1.2636 | 1.0611 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 59.85 | 27.76 | 7782 | 6062 | 1.2836 | 1.0653 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.56 | 27.76 | 593 | 6217 | 0.0954 | 0.4802 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.56 | 27.76 | 8854 | 6217 | 1.4241 | 1.0927 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.56 | 27.76 | 8067 | 6217 | 1.2975 | 1.0678 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 61.56 | 27.76 | 8167 | 6217 | 1.3136 | 1.0711 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.26 | 27.76 | 583 | 6465 | 0.0902 | 0.4728 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.26 | 27.76 | 9205 | 6465 | 1.4237 | 1.0919 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.26 | 27.76 | 8390 | 6465 | 1.2976 | 1.0674 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 63.26 | 27.76 | 8508 | 6465 | 1.3159 | 1.0710 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.97 | 27.76 | 656 | 6656 | 0.0985 | 0.4919 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.97 | 27.76 | 9604 | 6656 | 1.4427 | 1.0949 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.97 | 27.76 | 8641 | 6656 | 1.2981 | 1.0671 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 64.97 | 27.76 | 8806 | 6656 | 1.3229 | 1.0721 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.67 | 27.76 | 671 | 6695 | 0.1002 | 0.4955 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.67 | 27.76 | 9980 | 6695 | 1.4905 | 1.1034 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.67 | 27.76 | 8989 | 6695 | 1.3425 | 1.0758 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 66.67 | 27.76 | 9136 | 6695 | 1.3645 | 1.0801 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 68.37 | 27.76 | 712 | 6879 | 0.1035 | 0.5037 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 68.37 | 27.76 | 10290 | 6879 | 1.4958 | 1.1039 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 68.37 | 27.76 | 9255 | 6879 | 1.3454 | 1.0760 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 68.37 | 27.76 | 9418 | 6879 | 1.3691 | 1.0806 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 70.08 | 27.76 | 643 | 6849 | 0.0939 | 0.4851 | MN20160318_Q01 | I14 |